- Home
- ARQQ vs LVTX Comparison
ARQQ vs LVTX Comparison
Compare ARQQ & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQQ
- LVTX
- Stock Information
- Founded
- ARQQ 2017
- LVTX 2016
- Country
- ARQQ United Kingdom
- LVTX Netherlands
- Employees
- ARQQ N/A
- LVTX N/A
- Industry
- ARQQ Computer Software: Prepackaged Software
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- ARQQ Technology
- LVTX Health Care
- Exchange
- ARQQ Nasdaq
- LVTX Nasdaq
- Market Cap
- ARQQ 531.6M
- LVTX 33.9M
- IPO Year
- ARQQ N/A
- LVTX 2021
- Fundamental
- Price
- ARQQ $36.54
- LVTX $1.48
- Analyst Decision
- ARQQ Strong Buy
- LVTX Hold
- Analyst Count
- ARQQ 1
- LVTX 3
- Target Price
- ARQQ $52.00
- LVTX $1.75
- AVG Volume (30 Days)
- ARQQ 1.3M
- LVTX 11.5K
- Earning Date
- ARQQ 05-22-2025
- LVTX 08-19-2025
- Dividend Yield
- ARQQ N/A
- LVTX N/A
- EPS Growth
- ARQQ N/A
- LVTX N/A
- EPS
- ARQQ 0.48
- LVTX N/A
- Revenue
- ARQQ $241,000.00
- LVTX $4,990,000.00
- Revenue This Year
- ARQQ $1,818.77
- LVTX N/A
- Revenue Next Year
- ARQQ N/A
- LVTX N/A
- P/E Ratio
- ARQQ $75.25
- LVTX N/A
- Revenue Growth
- ARQQ N/A
- LVTX N/A
- 52 Week Low
- ARQQ $3.72
- LVTX $0.85
- 52 Week High
- ARQQ $52.79
- LVTX $2.39
- Technical
- Relative Strength Index (RSI)
- ARQQ 55.94
- LVTX 75.38
- Support Level
- ARQQ $34.50
- LVTX $1.27
- Resistance Level
- ARQQ $41.40
- LVTX $1.40
- Average True Range (ATR)
- ARQQ 3.86
- LVTX 0.05
- MACD
- ARQQ -0.62
- LVTX 0.01
- Stochastic Oscillator
- ARQQ 37.75
- LVTX 95.72
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.